Nationwide screening identifies an expanded clinical spectrum of anti-KLHL11 antibody-associated neurologic disease in Japan. Pan J, Yaguchi H, Kudo A, Fujii S, et al. J Neurol 2026;273:321.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Pan J, Yaguchi H, Kudo A, Fujii S, et al. Nationwide screening identifies an expanded clinical spectrum of anti-KLHL11 antibody-associated neurologic disease in Japan. J Neurol 2026;273:321.
PMID: 42154290